Darvas, Martin

The paraventricular thalamus controls a central amygdala fear circuit

Penzo, M. A., Robert, V., Tucciarone, J., De Bundel, D., Wang, M., Van Aelst, L., Darvas, M., Parada, L. F., Palmiter, R. D., He, M., et al. (2015) · Nature

Memory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cited by 506

Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior

Zweifel, L. S., Parker, J. G., Lobb, C. J., Rainwater, A., Wall, V. Z., Fadok, J. P., Darvas, M., Kim, M. J., Mizumori, S. J. Y., Paladini, C. A., et al. (2009) · Proceedings of the National Academy of Sciences

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 426

Integrated multimodal cell atlas of Alzheimer’s disease

Gabitto, M. I., Travaglini, K. J., Rachleff, V. M., Kaplan, E. S., Long, B., Ariza, J., Ding, Y., Mahoney, J. T., Dee, N., Goldy, J., et al. (2023) · Nature Neuroscience

Alzheimer's disease research and treatmentsSingle-cell and spatial transcriptomics

Cited by 425

Integrated multimodal cell atlas of Alzheimer’s disease

Gabitto, M. I., Travaglini, K. J., Rachleff, V. M., Kaplan, E. S., Long, B., Ariza, J., Ding, Y., Mahoney, J. T., Dee, N., Goldy, J., et al. (2024) · Nature Neuroscience

Alzheimer's disease research and treatmentsSingle-cell and spatial transcriptomics

Cited by 397

Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome

Staedtke, V., Bai, R.-Y., Kim, K., Darvas, M., Davila, M. L., Riggins, G. J., Rothman, P. B., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., et al. (2018) · Nature

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 277

Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson’s Disease

McKinley, J. W., Shi, Z., Kawikova, I., Hur, M., Bamford, I. J., Sudarsana Devi, S. P., Vahedipour, A., Darvas, M., & Bamford, N. S. (2019) · Neuron

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 130

The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease

Wainberg, M., Luquez, T., Koelle, D. M., Readhead, B., Johnston, C., Darvas, M., & Funk, C. C. (2021) · Molecular Psychiatry

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 74

Sleep-deprived cognitive impairment in aging mice is alleviated by rapamycin

Mukherjee, K., Lee, A. J., Zhu, L., Darvas, M., & Ladiges, W. (2019) · Aging Pathobiology and Therapeutics

Sleep and Wakefulness ResearchSleep and Work-Related Fatigue

Cited by 10

A cocktail of rapamycin, acarbose, and phenylbutyrate prevents age-related cognitive decline in mice by targeting multiple aging pathways

Jiang, Z., He, Q., Wezeman, J., Darvas, M., & Ladiges, W. (2024) · GeroScience

Genetics, Aging, and Longevity in Model OrganismsAntioxidants, Aging, Portulaca oleracea

Cited by 10

The rationale for testing drug combinations in aging intervention studies

Sharma, K., Wang, J., Jiang, Z., Klug, J., Darvas, M., M. Imai, D., Snider, T., Niedernhofer, L., & Ladiges, W. (2019) · Aging Pathobiology and Therapeutics

Genetics, Aging, and Longevity in Model OrganismsTelomeres, Telomerase, and Senescence

Cited by 4

A drug cocktail of rapamycin, acarbose, and phenylbutyrate enhances resilience to features of early-stage Alzheimer’s disease in aging mice

Wezeman, J., Darvas, M., Postupna, N., Klug, J., Mangalindan, R. S., Keely, A., Nguyen, K., Johnson, C., Rosenfeld, M., & Ladiges, W. (2024) · bioRxiv (Cold Spring Harbor Laboratory)

Alzheimer's disease research and treatmentsGenetics, Aging, and Longevity in Model Organisms

Cited by 3